PDB Short entry for 3GXL HEADER TRANSFERASE 02-APR-09 3GXL TITLE ALK-5 KINASE COMPLEX WITH GW857175 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 201-503; COMPND 5 SYNONYM: TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I, TGF-BETA COMPND 6 RECEPTOR TYPE I, TGF-BETA TYPE I RECEPTOR, TBETAR-I, TGFR-1, COMPND 7 SERINE/THREONINE-PROTEIN KINASE RECEPTOR R4, SKR4, ACTIVIN RECEPTOR- COMPND 8 LIKE KINASE 5, ALK-5; COMPND 9 EC: 2.7.11.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TGF-BETA, ALK5, KINASE, INHIBITOR, QUINAZOLINE, AORTIC ANEURYSM, ATP- KEYWDS 2 BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, KEYWDS 3 GLYCOPROTEIN, MAGNESIUM, MANGANESE, MEMBRANE, METAL-BINDING, KEYWDS 4 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, KEYWDS 5 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR W.SMITH,C.JANSON REVDAT 3 01-NOV-23 3GXL 1 REMARK REVDAT 2 01-NOV-17 3GXL 1 REMARK REVDAT 1 21-APR-09 3GXL 0 JRNL AUTH F.GELLIBERT,M.-H.FOUCHET,V.-L.NGUYEN,R.WANG,G.KRYSA, JRNL AUTH 2 A.-C.DE GOUVILLE,S.HUET,N.DODIC JRNL TITL DESIGN OF NOVEL QUINAZOLINE DERIVATIVES AND RELATED JRNL TITL 2 ANALOGUES AS POTENT AND SELECTIVE ALK5 INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 19 2277 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19285388 JRNL DOI 10.1016/J.BMCL.2009.02.087 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1226 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2296 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.43500 REMARK 3 B22 (A**2) : -8.23000 REMARK 3 B33 (A**2) : 1.79500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.887 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.510 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.292 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.041 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GXL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052432. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26984 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.9930 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.71300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1B6C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.91950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.82600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.30900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.82600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.91950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.30900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 25 REMARK 465 GLY A 26 REMARK 465 GLU A 27 REMARK 465 ILE A 167 REMARK 465 ALA A 168 REMARK 465 PRO A 169 REMARK 465 ASN A 170 REMARK 465 HIS A 171 REMARK 465 ILE A 217 REMARK 465 GLY A 218 REMARK 465 GLY A 219 REMARK 465 TRP A 258 REMARK 465 GLN A 259 REMARK 465 GLU A 299 REMARK 465 GLY A 300 REMARK 465 ILE A 301 REMARK 465 LYS A 302 REMARK 465 MET A 303 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 124 50.52 -109.61 REMARK 500 ASP A 133 39.38 -157.73 REMARK 500 ASP A 151 86.88 33.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 224 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE LIGAND IS QUINAZOLINE ATP-COMPETITIVE INHIBITOR. THE CODE BY REMARK 600 THE DEPOSITOR IS GW857175. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QIG A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GXJ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH GW855857 DBREF 3GXL A 1 303 UNP P36897 TGFR1_HUMAN 201 503 SEQRES 1 A 303 ILE ALA ARG THR ILE VAL LEU GLN GLU SER ILE GLY LYS SEQRES 2 A 303 GLY ARG PHE GLY GLU VAL TRP ARG GLY LYS TRP ARG GLY SEQRES 3 A 303 GLU GLU VAL ALA VAL LYS ILE PHE SER SER ARG GLU GLU SEQRES 4 A 303 ARG SER TRP PHE ARG GLU ALA GLU ILE TYR GLN THR VAL SEQRES 5 A 303 MET LEU ARG HIS GLU ASN ILE LEU GLY PHE ILE ALA ALA SEQRES 6 A 303 ASP ASN LYS ASP ASN GLY THR TRP THR GLN LEU TRP LEU SEQRES 7 A 303 VAL SER ASP TYR HIS GLU HIS GLY SER LEU PHE ASP TYR SEQRES 8 A 303 LEU ASN ARG TYR THR VAL THR VAL GLU GLY MET ILE LYS SEQRES 9 A 303 LEU ALA LEU SER THR ALA SER GLY LEU ALA HIS LEU HIS SEQRES 10 A 303 MET GLU ILE VAL GLY THR GLN GLY LYS PRO ALA ILE ALA SEQRES 11 A 303 HIS ARG ASP LEU LYS SER LYS ASN ILE LEU VAL LYS LYS SEQRES 12 A 303 ASN GLY THR CYS CYS ILE ALA ASP LEU GLY LEU ALA VAL SEQRES 13 A 303 ARG HIS ASP SER ALA THR ASP THR ILE ASP ILE ALA PRO SEQRES 14 A 303 ASN HIS ARG VAL GLY THR LYS ARG TYR MET ALA PRO GLU SEQRES 15 A 303 VAL LEU ASP ASP SER ILE ASN MET LYS HIS PHE GLU SER SEQRES 16 A 303 PHE LYS ARG ALA ASP ILE TYR ALA MET GLY LEU VAL PHE SEQRES 17 A 303 TRP GLU ILE ALA ARG ARG CYS SER ILE GLY GLY ILE HIS SEQRES 18 A 303 GLU ASP TYR GLN LEU PRO TYR TYR ASP LEU VAL PRO SER SEQRES 19 A 303 ASP PRO SER VAL GLU GLU MET ARG LYS VAL VAL CYS GLU SEQRES 20 A 303 GLN LYS LEU ARG PRO ASN ILE PRO ASN ARG TRP GLN SER SEQRES 21 A 303 CYS GLU ALA LEU ARG VAL MET ALA LYS ILE MET ARG GLU SEQRES 22 A 303 CYS TRP TYR ALA ASN GLY ALA ALA ARG LEU THR ALA LEU SEQRES 23 A 303 ARG ILE LYS LYS THR LEU SER GLN LEU SER GLN GLN GLU SEQRES 24 A 303 GLY ILE LYS MET HET QIG A 999 27 HETNAM QIG N-1H-INDAZOL-5-YL-2-(6-METHYLPYRIDIN-2-YL)QUINAZOLIN-4- HETNAM 2 QIG AMINE FORMUL 2 QIG C21 H16 N6 FORMUL 3 HOH *137(H2 O) HELIX 1 1 ILE A 1 ILE A 5 5 5 HELIX 2 2 SER A 35 ARG A 37 5 3 HELIX 3 3 GLU A 38 GLN A 50 1 13 HELIX 4 4 SER A 87 TYR A 95 1 9 HELIX 5 5 THR A 98 MET A 118 1 21 HELIX 6 6 THR A 175 MET A 179 5 5 HELIX 7 7 ALA A 180 ASP A 185 1 6 HELIX 8 8 HIS A 192 ARG A 214 1 23 HELIX 9 9 SER A 237 CYS A 246 1 10 HELIX 10 10 CYS A 261 GLU A 273 1 13 HELIX 11 11 ASN A 278 ARG A 282 5 5 HELIX 12 12 THR A 284 GLN A 298 1 15 SHEET 1 A 5 VAL A 6 LYS A 13 0 SHEET 2 A 5 GLU A 18 LYS A 23 -1 O VAL A 19 N GLY A 12 SHEET 3 A 5 VAL A 29 PHE A 34 -1 O VAL A 31 N TRP A 20 SHEET 4 A 5 THR A 74 SER A 80 -1 O LEU A 76 N PHE A 34 SHEET 5 A 5 PHE A 62 ASP A 69 -1 N ALA A 64 O VAL A 79 SHEET 1 B 2 ALA A 128 ALA A 130 0 SHEET 2 B 2 VAL A 156 HIS A 158 -1 O HIS A 158 N ALA A 128 SHEET 1 C 2 ILE A 139 VAL A 141 0 SHEET 2 C 2 CYS A 147 ILE A 149 -1 O CYS A 148 N LEU A 140 SITE 1 AC1 12 GLY A 14 ALA A 30 LYS A 32 TYR A 49 SITE 2 AC1 12 LEU A 78 SER A 80 ASP A 81 TYR A 82 SITE 3 AC1 12 HIS A 83 LEU A 140 ASP A 151 HOH A1001 CRYST1 41.839 74.618 89.652 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023901 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013402 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011154 0.00000